Patients Infected With HIV Since More Than 10 Years With a Plasma Viral RNA <400 Copies / mL in the Absence of Any Treatment: Study Mechanisms Involved in Controlling the Infection
ANRS CO18
ANRS HIV CONTROLLERS NATIONAL OBSERVATORY
1 other identifier
interventional
250
1 country
1
Brief Summary
The investigators have previously described a limited group of HIV-1-infected patients, we called HIV controllers (HIC), who have been infected for more than 10 years, in whom viral replication is spontaneously controlled without any treatment. These patients are defined according to virological criteria: more than 90% of the quantifications of plasma viral load should be less than 400 RNA copies/mL. The purpose of the ANRS EP36 study was to characterize these patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2009
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedFirst Submitted
Initial submission to the registry
February 8, 2010
CompletedFirst Posted
Study publicly available on registry
February 9, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2012
CompletedDecember 27, 2012
December 1, 2012
2 years
February 8, 2010
December 26, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
to allow the long-term follow-up of the HIV controllers. Epidemiological, clinical, virological, and immunological data will be collected.
Secondary Outcomes (1)
To understand the mechanisms involved in the control of the viral replication in HIC implies to study the patients in whom the viral control is lost and to compare them to the HIC in whom the control is preserved
Study Arms (1)
patient
NO INTERVENTIONInterventions
Epidemiological, clinical, virological, and immunological data will be collected. Clinical events as neoplasia will be collected
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- able to give written consent
- who have been infected for more than 5 years
- not treated by ARV
- HIV positive serology
- Covered by French Social Security
You may not qualify if:
- Covered by French Social Security
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Unknown Facility
Le Kremlin-Bicêtre, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
JP Faller, MD
CH Belfort
- PRINCIPAL INVESTIGATOR
Pascal Roblot, PHD
CHU Poitiers
- PRINCIPAL INVESTIGATOR
Gilles Beaucaire, MD
CHU Pointe à Pitre
- PRINCIPAL INVESTIGATOR
Christine Rouger, MD
Hôpital Robert Debré REIMS
- PRINCIPAL INVESTIGATOR
Jean Luc Delassus, MD
CHI Ballanger Aulnay sous Bois
- PRINCIPAL INVESTIGATOR
Alain Devidas, MD
Hopital Gilles De Corbeil Corbeil
- PRINCIPAL INVESTIGATOR
Louis Bubertet
Hopital St Louis Paris
- PRINCIPAL INVESTIGATOR
Michèle Bentata, MD
Hopital Avicenne BOBIGNY
- PRINCIPAL INVESTIGATOR
Alexandra Compagnucci, MD
Hopital Hotel Dieu Paris
- PRINCIPAL INVESTIGATOR
Philippe Genet, PHD
Hopital Victore Dupouy Argenteuil
- PRINCIPAL INVESTIGATOR
Olivier Patey, PHD
CHI Villeneuve St Goerges
- PRINCIPAL INVESTIGATOR
Marie Christine Drobacheff, MD
CHU St Jacques Besancon
- PRINCIPAL INVESTIGATOR
Helder Gil, MD
CHU Minjoz Besanson
- PRINCIPAL INVESTIGATOR
Eric Oksenhendler, PHD
Hopital St Louis Paris
- PRINCIPAL INVESTIGATOR
Frédéric Lucht, PHD
Hopital Bellevue St Etienne
- PRINCIPAL INVESTIGATOR
Michel Dupon, PHD
Hopital Pellegrin Bordeaux
- PRINCIPAL INVESTIGATOR
Jean Luc Schmit, MD
Hôpital Nord Amiens
- PRINCIPAL INVESTIGATOR
Daniel Sereni, PHD
St Louis ¨Paris
- PRINCIPAL INVESTIGATOR
JP Viard, MD
Hotel Dieu Paris
- PRINCIPAL INVESTIGATOR
JP Bru, MD
CH Annecy
- PRINCIPAL INVESTIGATOR
JF Delfraissy, PHD
Le Kremlin Bicetre
- PRINCIPAL INVESTIGATOR
Gilles Pichancourt
CH Henri Duffaut Avignon
- PRINCIPAL INVESTIGATOR
André Pierre Blanc, MD
CH du payx d'Aix
- PRINCIPAL INVESTIGATOR
Alain Lafeuillade, MD
Hopital Chalucet Toulon
- PRINCIPAL INVESTIGATOR
Christophe Rapp, PHD
Hopital Inter Armées Bégin St Mandé
- PRINCIPAL INVESTIGATOR
Pierre De Truchis, MD
Hopital Raymond Pointcarré Garches
- PRINCIPAL INVESTIGATOR
Vincent Jeantils, MD
Hopital Jean Verdier Bondy
- PRINCIPAL INVESTIGATOR
Daniel Vittecoq, PHD
Hopital Paul Brousse Villejuif
- PRINCIPAL INVESTIGATOR
Gilles Pialoux, PHD
Hopital Tenon Paris
- PRINCIPAL INVESTIGATOR
Olivier Bouchaud, PHD
Hopital Avicenne Bobigny
- PRINCIPAL INVESTIGATOR
Francois Boué, PHD
Hopital Antoine Béclère Clamart
- PRINCIPAL INVESTIGATOR
Laurence Weiss, PHD
HEGP Paris
- PRINCIPAL INVESTIGATOR
Dominique Salmon Ceron, PHD
Cochin
- PRINCIPAL INVESTIGATOR
Olivier Bletry, PHD
Hopital Foch Suresnes
- PRINCIPAL INVESTIGATOR
Emmanuel Mortier, MD
Louis Mourier Paris
- PRINCIPAL INVESTIGATOR
Alain Sobel, PHD
Hopital Henri Mondor Créteil
- PRINCIPAL INVESTIGATOR
Christine Katlama, PHD
Pitié Salpétrière Paris
- PRINCIPAL INVESTIGATOR
Anne Simon, MD
Pitié Salpétrière Paris
- PRINCIPAL INVESTIGATOR
Pierre Marie Girard, PHD
St Antoine Paris
- PRINCIPAL INVESTIGATOR
JM Molina, PHD
St Louis Paris
- PRINCIPAL INVESTIGATOR
André Cabié, MD
Hopital Pierre Zobda Quitman Fort de France
- PRINCIPAL INVESTIGATOR
JM Chennebault, MD
University Hospital, Angers
- PRINCIPAL INVESTIGATOR
Philippe Morlat, PHD
Hopital St André Bordeaux
- PRINCIPAL INVESTIGATOR
Pierre Weinbreck, PHD
CHU Limoges
- PRINCIPAL INVESTIGATOR
JL Tourraine, PHD
Hopital Edouard Herriot - Lyon
- PRINCIPAL INVESTIGATOR
Christian Trépo, PHD
Hopital Hotel Dieu Lyon
- PRINCIPAL INVESTIGATOR
Isabelle Poizot Martin, MD
Ste Marguerite Marseille
- PRINCIPAL INVESTIGATOR
Sophie Matheron, MD
Hopital Bichat, Paris
- PRINCIPAL INVESTIGATOR
François Raffi, PHD
Hopital Hotel Dieu Nantes
- PRINCIPAL INVESTIGATOR
Philippe Perré, MD
CH La Roche sur Yon
- PRINCIPAL INVESTIGATOR
Pierre Delomonica, PHD
Hopital l'Archet Nice
- PRINCIPAL INVESTIGATOR
Eric Rosenthal, PHD
Hopital l'Archet Nice
- PRINCIPAL INVESTIGATOR
Christian Michelet, PHD
Rennes University Hospital
- PRINCIPAL INVESTIGATOR
David Rey, MD
CHU Strasbourg
- PRINCIPAL INVESTIGATOR
JM Besnier, PHD
Hopital Bretonneau Tours
- PRINCIPAL INVESTIGATOR
Bruno Marchou, PHD
CHU Purpan (Toulouse)
- PRINCIPAL INVESTIGATOR
Renaud Verdon, PHD
Hopital de la côte de Nacre Caen
- PRINCIPAL INVESTIGATOR
Christine Jacomet, MD
Hopital Hotel Dieu Clermont Ferrand
- PRINCIPAL INVESTIGATOR
Lionel Piroth, MD
CHU Dijon
- PRINCIPAL INVESTIGATOR
Pascale Leclercq, MD
Hopital Albet Michallon Grenoble
- STUDY DIRECTOR
Yazdan Yazdanpanah, PHD
Hopital Gustave Dron Tourcoing
- PRINCIPAL INVESTIGATOR
Thierry May, PHD
Hopital de Brabois Nancy
- PRINCIPAL INVESTIGATOR
Francois Caron, PHD
chu Rouen
- PRINCIPAL INVESTIGATOR
Patrick Mercié, PHD
St André Bordeaux
- PRINCIPAL INVESTIGATOR
Claire Series, PHD
Hopital Pellegrin Bordeaux
- PRINCIPAL INVESTIGATOR
Philippe Granier, MD
CH Bourg en Bresse
- PRINCIPAL INVESTIGATOR
Marc Gatfosse, MD
CH rené Arbeltier Coulomniers
- PRINCIPAL INVESTIGATOR
Patrice Poubeau, MD
Groupe Hospitalier Sud Reunion St Pierre de la Réunion
- PRINCIPAL INVESTIGATOR
Agnès Uludag, MD
Hopital Beaujon Clichy
- PRINCIPAL INVESTIGATOR
Philippe Arsac, MD
CHR Orléans
- PRINCIPAL INVESTIGATOR
Isabelle Delacroix, MD
CH intercommunal Créteil
- PRINCIPAL INVESTIGATOR
Vincent Daneluzzi, MD
CASH Nanterre
- PRINCIPAL INVESTIGATOR
Elisabeth Rouveix, MD
Hôpital Ambroise Paré Boulogne
- PRINCIPAL INVESTIGATOR
Goerges Diab, MD
CH Noyon
- PRINCIPAL INVESTIGATOR
Geneviève Berck Wirth
CH Mulhouse
- PRINCIPAL INVESTIGATOR
Philippe Romand, MD
CHI Les hopitaux du Léman Thonon les Bains
- PRINCIPAL INVESTIGATOR
Laurent Blum, MD
Hopital René Dubois Pontoise
- PRINCIPAL INVESTIGATOR
Christophe Michau, MD
CH St Nazaire
- PRINCIPAL INVESTIGATOR
Raymond Armero, MD
CHI Fréjus St Raphaël
- PRINCIPAL INVESTIGATOR
Bernard Christian, MD
Hopital Notre Dame de Bon Secours Metz
- PRINCIPAL INVESTIGATOR
Philippe Muller, MD
Hopital Beauregard Thionville
- PRINCIPAL INVESTIGATOR
Henri Jardel, MD
CH Bretagne Atlantique Vannes
- PRINCIPAL INVESTIGATOR
Elisabeth Carbonnel, MD
Hôpital Simone Weil Eaubonne
- PRINCIPAL INVESTIGATOR
Laurent Hocqueloux, MD
Hopital La source Orléans
- PRINCIPAL INVESTIGATOR
Marie Odile Lemaitre, MD
CH Juvisy sur Orge
- PRINCIPAL INVESTIGATOR
Patrick Philibert, MD
Hopital Ambroise Paré Marseille
- PRINCIPAL INVESTIGATOR
Paul Henry Consigny, MD
Institut Pasteur Paris
- PRINCIPAL INVESTIGATOR
JM Ragnaud, PHD
Hopital Pellegrin Bordeaux
- PRINCIPAL INVESTIGATOR
Daniel Garipuy, MD
Hopital Joseph Ducuing Toulouse
- PRINCIPAL INVESTIGATOR
Beuscart MD Claude
CHU St Brieuc
- PRINCIPAL INVESTIGATOR
Leprêtre MD Annie
Hôpital Simone Veil - Eaubonne
- PRINCIPAL INVESTIGATOR
Duvivier MD Claudine
Institut Pasteur Paris
- PRINCIPAL INVESTIGATOR
Garipuy MD Daniel
Hôpital Joseph Ducuing Toulouse
- PRINCIPAL INVESTIGATOR
Aumaitre MD Hugues
Centre hospitalier de Perpignan
- PRINCIPAL INVESTIGATOR
Rami MD Agathe
Lariboisière Paris
- PRINCIPAL INVESTIGATOR
De Lavassière MD Marc
CH Général Montauban
- PRINCIPAL INVESTIGATOR
Miailhes MD Patrick
Hôpital Croix Rousse Lyon
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 8, 2010
First Posted
February 9, 2010
Study Start
March 1, 2009
Primary Completion
March 1, 2011
Study Completion
March 1, 2012
Last Updated
December 27, 2012
Record last verified: 2012-12